Show simple item record

dc.contributor.authorTanuri, A.
dc.contributor.authorCaridea, E.
dc.contributor.authorDantas, M. C.
dc.contributor.authorMorgado, M. G.
dc.contributor.authorMello, DLC
dc.contributor.authorBorges, S.
dc.contributor.authorTavares, M.
dc.contributor.authorFerreira, S. B.
dc.contributor.authorSantoro-Lopes, G.
dc.contributor.authorMartins, CRF
dc.contributor.authorEsteves, ALC
dc.contributor.authorDiaz, R. S.
dc.contributor.authorAndreo, SMS
dc.contributor.authorFerreira, LAP
dc.contributor.authorRodrigues, R.
dc.contributor.authorReuter, T.
dc.contributor.authorCavalcanti, AMS
dc.contributor.authorOliveira, S. M. de
dc.contributor.authorBarbosa, H. B. de
dc.contributor.authorTeixeira, P. R.
dc.contributor.authorChequer, P. N.
dc.date.accessioned2016-01-24T12:33:26Z
dc.date.available2016-01-24T12:33:26Z
dc.date.issued2002-07-01
dc.identifierhttp://dx.doi.org/10.1016/S1386-6532(01)00249-9
dc.identifier.citationJournal of Clinical Virology. Amsterdam: Elsevier B.V., v. 25, n. 1, p. 39-46, 2002.
dc.identifier.issn1386-6532
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/26913
dc.description.abstractBackground: Current guidelines for antiretroviral (ARV) therapy recommend at least triple-drug combination, the so-called highly active antiretroviral therapy (HAART). Not all patients respond to HAART and the development of drug resistance remains one of the most serious obstacles to sustained suppression of HIV. Objective: in an attempt to correlate the HIV therapeutic failure with reverse transcriptase (RT) and protease resistance mutations, we describe the ARV resistance profile in patients failing HAART in Brazil. We studied 267 Brazilian HIV-1 infected patients failing HAART looking for mutations in RT and protease genes. the mutation profile of the viruses infecting these individuals were deduced and correlated to laboratorial parameters. Study Design: Two different HIV-1 genomic regions were targeted for PCR amplification, the protease (pro) and pal RT (palm finger region) genes. the mutations related to drug resistance in RT gene was analyzed using a line probe assay (LIPA(R)) and pro amino acids positions 82 and 90 were screened through RFLP using HincII restriction digestion. Results: There was strong correlation between the mutation in the pro and RT genes and therapeutic failure. the main mutation found in RT gene was the M184V (48%) followed by T69D/N (47%), T215Y/F (46%), M41L (39%), and L74V (7%). in the pro gene the main mutation found was L90M (26%) followed by dual substitution in L90M and V82A (6%). All mutations profiles matched very well with the patients drug regimen. Conclusions: This study has shown that 84.7% of HIV infected subjects failing HAART for more than 3 months presented viral genomic mutations associated with drug resistance. (C) 2002 Elsevier Science B.V. All rights reserved.en
dc.format.extent39-46
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofJournal of Clinical Virology
dc.rightsAcesso restrito
dc.subjectHIV-1en
dc.subjectproteaseen
dc.subjectreverse transcriptaseen
dc.subjectphenotypingen
dc.subjectgenotypingen
dc.titlePrevalence of mutations related to HIV-1 antiretroviral resistance in Brazilian patients failing HAARTen
dc.typeArtigo
dc.rights.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.contributor.institutionUniversidade Federal do Rio de Janeiro (UFRJ)
dc.contributor.institutionBrazilian Minist Hlth
dc.contributor.institutionFiocruz MS
dc.contributor.institutionUniv Fed Espirito Santos
dc.contributor.institutionUniversidade de Brasília (UnB)
dc.contributor.institutionLab Cent Saude Publ
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionUniversidade Federal de Santa Catarina (UFSC)
dc.description.affiliationUniv Fed Rio de Janeiro, CCS, Inst Biol, Dept Genet,Lab Virol Mol, BR-21944970 Rio de Janeiro, Brazil
dc.description.affiliationBrazilian Minist Hlth, Programa Brasileiro AIDS STD, Brasilia, DF, Brazil
dc.description.affiliationFiocruz MS, Inst Oswaldo Cruz, Lab Imunol, BR-21045900 Rio de Janeiro, Brazil
dc.description.affiliationUniv Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Petrobras, BR-21944970 Rio de Janeiro, Brazil
dc.description.affiliationUniv Fed Espirito Santos, Vitoria, ES, Brazil
dc.description.affiliationUniv Brasilia, Virol Lab, Brasilia, DF, Brazil
dc.description.affiliationLab Cent Saude Publ, Recife, PE, Brazil
dc.description.affiliationUniv Fed Estado São Paulo, Lab Retrovirol, São Paulo, Brazil
dc.description.affiliationUniv São Paulo, Dept Epidemiol, São Paulo, Brazil
dc.description.affiliationLab Cent Saude Publ, Florianopolis, SC, Brazil
dc.description.affiliationUniv Fed Santa Catarina, Florianopolis, SC, Brazil
dc.description.affiliationUnifespUniv Fed Estado São Paulo, Lab Retrovirol, São Paulo, Brazil
dc.identifier.doi10.1016/S1386-6532(01)00249-9
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000177400900005


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record